Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biodesix Q3 2023 EPS $(0.14) Beats $(0.15) Estimate, Sales $13.49M Miss $14.36M Estimate

Author: Benzinga Newsdesk | November 07, 2023 05:15pm
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 58.82 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $13.49 million which missed the analyst consensus estimate of $14.36 million by 6.05 percent. This is a 21.46 percent increase over sales of $11.11 million the same period last year.

Posted In: BDSX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist